A pharmacist holding an MBA from the University of Florida, Sherif El-Refai recently began a doctoral program at the University of Kentucky. Pursuing a PhD in pharmaceutical sciences, Sherif El-Refai concurrently works at the Markey Cancer Center, where he serves as an oncology pharmacist.
A cancer center designated by the National Cancer Institute, the Markey Cancer Center focuses on developing research studies that enhance therapies offered to patients diagnosed with various forms of the disease. In 2009, the university’s center was awarded a Specialized Programs of Research Excellence (SPORE) grant. One of only six cancer centers to receive the grant, the organization obtained $1.5 million in funding to support studies on colon and liver cancer.
Employing tissue procurement and analysis as well as biostatistics, the research team, led by Dr. B. Mark Evers, evaluates tumor stroma, mucosa, and colorectal cancer cases to locate the underlying components that progress colorectal cancer. In terms of liver cancer, researchers are looking for a direct link between hepatitis C virus proteins and the disease.